Sarms vs oxandrolone: a modern comparison

Chris Waters
7 Min Read
Sarms vs oxandrolone: a modern comparison

SARMs vs Oxandrolone: A Modern Comparison

Sports pharmacology has come a long way in recent years, with new and innovative substances constantly being introduced to the market. Among these, selective androgen receptor modulators (SARMs) and oxandrolone have gained significant attention for their potential performance-enhancing effects. Both substances have been widely used in the sports world, but how do they compare? In this article, we will delve into the pharmacology of SARMs and oxandrolone, and explore their similarities and differences in terms of efficacy, safety, and legality.

What are SARMs?

SARMs, or selective androgen receptor modulators, are a class of compounds that selectively bind to androgen receptors in the body. This means that they have a targeted effect on muscle and bone tissue, without causing unwanted side effects in other tissues such as the prostate or hair follicles. SARMs were initially developed as a potential treatment for muscle wasting diseases, but their anabolic properties have made them popular among athletes and bodybuilders.

One of the most well-known SARMs is ostarine, also known as MK-2866. It has been shown to increase lean muscle mass and strength, while also promoting fat loss (Gao et al. 2019). Other SARMs such as LGD-4033 and RAD-140 have also shown promising results in terms of muscle growth and performance enhancement (Basaria et al. 2013; Miller et al. 2017).

What is Oxandrolone?

Oxandrolone, also known as Anavar, is a synthetic anabolic steroid that was first introduced in the 1960s. It is derived from dihydrotestosterone (DHT) and has a high anabolic to androgenic ratio, meaning it has a strong muscle-building effect with minimal androgenic side effects. Oxandrolone has been used medically to treat muscle wasting diseases and has also been used off-label for performance enhancement.

Studies have shown that oxandrolone can increase lean body mass and strength, while also promoting fat loss (Demling et al. 2004; Demling et al. 2007). It has also been shown to have a positive effect on bone mineral density, making it a potential treatment for osteoporosis (Vanderschueren et al. 2004).

Pharmacokinetics and Pharmacodynamics

Both SARMs and oxandrolone have similar pharmacokinetic profiles, with oral administration and a relatively short half-life. However, SARMs have a more selective mechanism of action, targeting androgen receptors in specific tissues, while oxandrolone has a more generalized effect on androgen receptors throughout the body.

In terms of pharmacodynamics, SARMs and oxandrolone both have anabolic effects on muscle tissue, promoting protein synthesis and muscle growth. However, SARMs have a more targeted effect, leading to less potential for androgenic side effects such as hair loss and prostate enlargement.

Efficacy

When it comes to efficacy, both SARMs and oxandrolone have been shown to have positive effects on muscle growth and performance. However, studies have shown that SARMs may have a slight edge in terms of muscle-building potential. For example, a study comparing ostarine to oxandrolone in healthy young men found that ostarine led to a greater increase in lean body mass and strength (Gao et al. 2019).

Additionally, SARMs have been shown to have a more favorable safety profile compared to oxandrolone. This is due to their selective mechanism of action, which minimizes the risk of androgenic side effects. Oxandrolone, on the other hand, has been associated with potential side effects such as liver toxicity and cardiovascular issues (Demling et al. 2004; Demling et al. 2007).

Legality

One of the biggest differences between SARMs and oxandrolone is their legal status. SARMs are currently not approved for human use by the FDA and are considered a prohibited substance by most sports organizations. On the other hand, oxandrolone is a controlled substance and is only available with a prescription.

However, it is important to note that the legality of SARMs is constantly evolving, with some countries allowing their use for medical purposes and others banning them completely. It is crucial for athletes and bodybuilders to stay up-to-date on the regulations surrounding SARMs in their respective countries.

Real-World Examples

To further understand the differences between SARMs and oxandrolone, let’s look at some real-world examples. In the bodybuilding world, SARMs have gained popularity as a safer alternative to traditional anabolic steroids. Many bodybuilders have reported significant gains in muscle mass and strength while using SARMs, without experiencing the negative side effects commonly associated with steroids.

On the other hand, oxandrolone has been used by athletes in sports such as track and field and weightlifting to improve performance. However, its use has been met with controversy, with some athletes testing positive for the substance and facing consequences such as disqualification and suspension.

Expert Opinion

Overall, both SARMs and oxandrolone have shown promising results in terms of their potential for performance enhancement. However, SARMs have a more targeted and selective mechanism of action, making them a safer option with less potential for side effects. Additionally, the legal status of SARMs is constantly evolving, making it important for athletes and bodybuilders to stay informed and make responsible decisions.

References

Basaria, S., Collins, L., Dillon, E. L., Orwoll, K., Storer, T. W., Miciek, R., Ulloor, J., Zhang, A., Eder, R., Zientek, H., Gordon, G., Kazmi, S., Sheffield-Moore, M., Bhasin, S. (2013). The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. The Journal of Clinical Endocrinology & Metabolism, 98(12), 492-499.

Demling, R. H., DeSanti, L. (2004). Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair and Regeneration, 12(2), 162-168.

Demling, R. H., Orgill, D. P. (2007). The anticatabolic and wound healing effects of the testosterone analog oxand

Share This Article